PT  - JOURNAL ARTICLE
AU  - Deeb, Omar El
AU  - Jalloul, Maya
TI  - Forecasting the outbreak of COVID-19 in Lebanon
AID  - 10.1101/2020.09.03.20187880
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.09.03.20187880
4099  - http://medrxiv.org/content/early/2020/09/05/2020.09.03.20187880.short
4100  - http://medrxiv.org/content/early/2020/09/05/2020.09.03.20187880.full
AB  - This note explores the spread of the Coronavirus disease 2019 (COVID-19) in Lebanon using available data until August 25th, 2020 and forecasts the number of infections until the end of September using four diffierent scenarios for mitigation measures reflected in the reproductive number Rt. Mitigation measures in Lebanon date back to early March soon after the first confirmed cases, and have been gradually lifted as of May. Thereafter, the country has witnessed a slow yet steady increase in the number of cases that has been significantly exacerbated after the explosion at Beirut harbor on August 4. Furthermore, we estimate the daily active cases in need of intensive care compared to the available number of beds and we assess accordingly that this capacity will be exhausted within a short span of time, unless severe measures are imposed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors have no funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ministry of Public Health in LebanonAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available upon request.